Protocol

Moxidectin in Onchocerciasis: Clinical Trial Protocols

Moxidectin in Onchocerciasis: Clinical Trial Protocols: MDGH-MOX-1006: A pharmacokinetic and safety study of moxidectin to identify an optimal dose for treatment of children 4 to 11 years.

English version

Stay up to date

Follow our work by signing up for our newsletter

Thank you for your interest in Medicines Development for Global Health.

‍Please check your email inbox and click the confirmation link to complete your subscription.

Oops! Something went wrong while submitting the form.

Navigate to

Affiliate websites

Get in touch

MDGH respectfully acknowledges the Traditional Owners of the land on which our office is located, the Wurundjeri people of the Kulin Nation, and pay our respect to their Elders past, present and emerging.

Medicines Development for Global Health Limited.
Level 1, 18 Kavanagh Street Southbank Victoria 3006 Australia.
ABN: 79 116 977 523